TY - JOUR AU - Tacão, Marta AU - Tavares, Rafael dos Santos AU - Teixeira, Pedro AU - Roxo, Inês AU - Ramalheira, Elmano AU - Ferreira, Sónia AU - Henriques, Isabel T1 - mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal T2 - Emerging Infectious Disease journal PY - 2017 VL - 23 IS - 8 SP - 1419 SN - 1080-6059 AB - Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes. KW - Gene, carbapenem, meropenem, colistin, polymixin KW - fluconazole KW - linezolid KW - co-resistance KW - antimicrobial KW - antibacterial KW - antibiotic KW - IncX4::mcr-1 KW - IncF::Tn1441d- blaKPC-3 KW - Escherichia coli ST744 KW - Klebsiella pneumoniae KW - multiresistance KW - Portugal KW - gene, carbapenem, meropenem, colistin, polymixin, fluconazole, linezolid, co-resistance, antimicrobial resistance, antibacterial, antibiotic KW - IncX4::mcr-1, IncF::Tn1441d- blaKPC-3, sequence type, Escherichia coli ST744, Klebsiella pneumoniae, multiresistance, Portugal, bacteria DO - 10.3201/eid2308.170162 UR - https://wwwnc.cdc.gov/eid/article/23/8/17-0162_article ER - End of Reference